Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 19.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | | -100.0% | 31.8% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | -8.5 | 0.0 | 0.0 | 0.0 |
| Gross profit | 19.7 | 0.0 | 0.0 | 8.5 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | 183032.6% | 0.0% | | |
| Research and development | 8.4 | 5.9 | 4.0 | 0.4 | 0.2 | 146,143.0 | 322,107.0 |
| General and administrative | 9.3 | 5.1 | 4.3 | 6.6 | 0.8 | 264,664.0 | 497,150.0 |
| EBITA | -17.3 | -10.9 | -8.2 | -7.0 | -1.0 | -410,807.0 | -818,692.0 |
| EBITA margin | -87.5% | | | -150672.0% | -28275.2% | | |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 565.0 |
| EBIT | -17.3 | -10.9 | -8.2 | -7.0 | -1.0 | -410,807.0 | -819,257.0 |
| EBIT margin | -87.5% | | | -150684.1% | -28291.2% | | |
| Pre-tax income | -19.5 | -10.9 | -8.6 | -11.6 | -1.1 | -420,200.0 | -817,993.0 |
| Income taxes | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -19.4 | -10.9 | -8.6 | -11.6 | -1.1 | -420,200.0 | -817,993.0 |
| Net margin | -98.4% | | | -250838.4% | -32389.3% | | |
| |
| Diluted EPS | ($1.04) | ($0.87) | ($0.87) | ($2.44) | ($0.35) | ($128,974.75) | |
| Shares outstanding (diluted) | 18.6 | 12.5 | 9.9 | 4.8 | 3.3 | 3.3 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|